Literature DB >> 10803602

Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy.

Y Takeda1, T Yoneda, M Demura, I Miyamori, H Mabuchi.   

Abstract

High sodium intake causes cardiac hypertrophy independently of increases in blood pressure. Aldosterone is synthesized in extraadrenal tissues such as blood vessels, brain, and heart. Effects of 8 weeks of high sodium intake on cardiac aldosterone synthesis, as well as cardiac structure, mass, and aldosterone production, levels of mRNA coding for aldosterone synthase (CYP11B2) and the angiotensin II AT1 receptor, were studied in normotensive Wistar-Kyoto (WKY) rats. Isolated rat hearts were perfused for 2 hr, and the perfusate was analyzed by high-performance liquid chromatography and mass spectrometry. Aldosterone synthase activity was estimated from the conversion of [14C]deoxycorticosterone to [14C]aldosterone. Levels of mRNA for CYP11B2 and AT1 receptor were determined by competitive polymerase chain reactions. A high sodium intake for 8 weeks produced left ventricular hypertrophy without elevation of blood pressure. Plasma aldosterone concentrations and plasma renin concentrations were decreased by high sodium intake. Aldosterone production, activity of aldosterone synthase, and expression of mRNA for CYP11B2 and AT1 receptor were increased in hearts of rats with high sodium intake. These results suggest that high sodium intake increases cardiac aldosterone synthesis, which may contribute to cardiac hypertrophy independently of the circulating renin-angiotensin-aldosterone system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10803602     DOI: 10.1210/endo.141.5.7529

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  29 in total

Review 1.  Aldosterone antagonists in the treatment of hypertension and target organ damage.

Authors:  S Rajagopalan; B Pitt
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  The cardiac renin-angiotensin system is responsible for high-salt diet-induced left ventricular hypertrophy in mice.

Authors:  Philippe Le Corvoisier; Christophe Adamy; Lucien Sambin; Bertrand Crozatier; Alain Berdeaux; Jean-Baptiste Michel; Luc Hittinger; JinBo Su
Journal:  Eur J Heart Fail       Date:  2010-09-24       Impact factor: 15.534

3.  Non-pressure-related effects of dietary sodium.

Authors:  Guilhem du Cailar; Albert Mimran
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

4.  Effect of Salvia miltiorrhiza on left ventricular hypertrophy and cardiac aldosterone in spontaneously hypertensive rats.

Authors:  Shaojie Han; Zhi Zheng; Dahong Ren
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

Review 5.  Aldosterone receptor blockade in the management of heart failure.

Authors:  Emiliano A Palmieri; Bernadette Biondi; Serafino Fazio
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

6.  Activation of TRPV1 attenuates high salt-induced cardiac hypertrophy through improvement of mitochondrial function.

Authors:  Hongmei Lang; Qiang Li; Hao Yu; Peng Li; Zongshi Lu; Shiqiang Xiong; Tao Yang; Yu Zhao; Xiaohu Huang; Peng Gao; Hexuan Zhang; Qianhui Shang; Daoyan Liu; Zhiming Zhu
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

7.  [Salt consumption and cardiovascular risk : a plea for salt reduction].

Authors:  M Middeke
Journal:  Internist (Berl)       Date:  2012-01       Impact factor: 0.743

8.  Endothelial cell swelling by aldosterone.

Authors:  H Oberleithner; S W Schneider; L Albermann; U Hillebrand; T Ludwig; C Riethmüller; V Shahin; C Schäfer; H Schillers
Journal:  J Membr Biol       Date:  2003-12-01       Impact factor: 1.843

9.  Prevention of salt induced hypertension and fibrosis by angiotensin converting enzyme inhibitors in Dahl S rats.

Authors:  B Liang; F H H Leenen
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

10.  Cirrhotic cardiomyopathy: review of pathophysiology and treatment.

Authors:  Maneerat Chayanupatkul; Suthat Liangpunsakul
Journal:  Hepatol Int       Date:  2014-07       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.